Loading
Latest filing published 23 Dec 2024 for IO Biotech, Inc., €8,131.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Amy Sullivan appears in our data through filings on IO Biotech, Inc. shares, published by SEC (Form 4). Between 17 March 2023 and 23 December 2024, the trades on record add up to 3 filings.
Every open-market trade on record is a purchase: 2 purchases worth €63k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant. 2024 to date brings 1 purchase and no sales.
The record was last updated on 23 December 2024 with an open-market purchase (€8,131) in IO Biotech, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations